Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,147Revenue $M71.0Net Margin (%)-41.8Z-Score5.1
Enterprise Value $M1,181EPS $-2.9Operating Margin %-34.4F-Score2
P/E(ttm))0Cash Flow Per Share $-5.0Pre-tax Margin (%)-41.3Higher ROA y-yN
Price/Book10410-y EBITDA Growth Rate %0Quick Ratio1.1Cash flow > EarningsY
Price/Sales28.15-y EBITDA Growth Rate %0Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-33.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-160.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M10.8ROI % (ttm)-49.2Gross Margin Increase y-yN

Gurus Latest Trades with FURX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
FURXMario Gabelli 2014-06-30 Buy 0.03%$75.24 - $105.3
($97.94)
$ 104.777%New holding, 54400 sh.54,400
FURXJohn Hussman 2010-09-30 Sold Out -0.01%$9.42 - $11.94
($10.59)
$ 104.77889%Sold Out0
FURXJohn Hussman 2010-06-30 Buy 0.01%$9.11 - $11.47
($10.4)
$ 104.77907%New holding, 62500 sh.62,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FURX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
FURX Mario Gabelli 2014-06-3054,4000.50.03New Buy
Premium Most recent portfolio changes are included for Premium Members only!


FURX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Forest Laboratories, LLC10% Owner 2014-07-02Buy11,169,066$9510.28view
Patel SailashCFO 2014-06-24Sell32,928$1040.74view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-24Sell10,368$104.120.62view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-18Sell45,691$104.110.63view
McIntyre Gail FrancesSenior Vice President-Research 2014-06-17Sell74,457$105.01-0.23view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-13Sell3,228$104.250.5view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-10Sell2,872$104.630.13view
McIntyre Gail FrancesSenior Vice President-Research 2014-06-10Sell1,746$104.580.18view
Patel SailashCFO 2014-06-10Sell1,504$104.680.09view
Almenoff June SheriePresident 2014-02-04Sell115,113$115.29-9.12view

Press Releases about FURX :

    Quarterly/Annual Reports about FURX:

    News about FURX:

    Articles On GuruFocus.com
    Look at All these Spinoffs Beating the Market Jul 06 2011 

    More From Other Websites
    FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 03 2014
    Salix Pharmaceuticals Surges on Positive IBS Data Jul 02 2014
    Actavis Completes Acquisition of Furiex Pharmaceuticals Jul 02 2014
    Actavis Completes Acquisition of Furiex Pharmaceuticals Jul 02 2014
    Actavis Completes Acquisition of Furiex Pharmaceuticals Jul 02 2014
    Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed... Jul 01 2014
    FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jul 01 2014
    U.S. allows Actavis Plc's purchase of Forest Labs with conditions Jun 30 2014
    Insider Trading Alert - FURX, EGP And FLT Traded By Insiders Jun 13 2014
    FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 28 2014
    INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of Furiex Pharmaceuticals, Inc. of Claims... May 23 2014
    SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection with the Sale of Furiex... May 22 2014
    FURIEX PHARMACEUTICALS, INC. Financials May 16 2014
    INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims... May 13 2014
    FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 09 2014
    FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 07 2014
    Furiex Pharmaceuticals Reports First Quarter 2014 Financial Results May 07 2014
    SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in... May 05 2014
    INVESTOR ALERT – FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the... May 02 2014
    SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc.... May 01 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide